Drawing for EZ2

USPTO serial 79298192

EZ2

Reviewed by CopyMark Law Group

Reg. 6822927Status 700Registered
Filing date
Status date
Registration date
Aug 23, 2022
Examiner
MAHONEY, PAULA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EZ2?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, nucleic acids, enzymes, polymerases, reagents for staining or marking, buffers, aqueous and non-aqueous solutions of alcohols and salts, distilled or purified water, silica-coated particles in liquid form; magnetic particles in liquid form; reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells, as well as for marking, separation, isolation, purification, amplification and analysis of biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances, in particular nucleic acids from biological and biochemical sample material; reagent kits comprising chemical, biochemical and biotechnological products, other than for medical or veterinary use, for sample preparation, purification, lysis, modification and manipulation of cells, as well as for marking, separation, isolation, purification, amplification and analysis of biopolymers, namely, nucleic acids, enzymes, proteins, macro molecules and biologically active materialsACTIVE
005Diagnostic agents and preparations for medical purposes; diagnostic preparations for medical and veterinary medical purposes, namely, nucleic acids, enzymes, polymerases, reagents for staining or marking, buffers, aqueous and non-aqueous solutions of alcohols and salts, distilled or purified water, silica and magnetic particles; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes for the preparation of samples, the modification and manipulation of samples and for marking, separation, isolation, purification, reproduction and analysis of biopolymers, namely, nucleic acids, enzymes, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample materials; reagent kits comprising essential diagnostic reagents and assays for medical and veterinary diagnostic purposes, namely, chemical, biochemical and biotechnological preparations for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic preparations for medical and veterinary purposes for marking, separation, isolation, purification, amplification and analysis of biopolymers, namely, enzymes, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biochemical and biotechnological sample materialsACTIVE
009Scientific apparatus, instruments and equipment, namely, sample preparation devices for isolation of nucleic acids and proteins for research, development and examination purposes; scientific apparatus, instruments and laboratory equipment, namely, thermocyclers and automated sample-processing platforms, not for medical use, for marking, separation, isolation, purification, amplification and analysis of biopolymers, in particular nucleic acids, proteins, macro molecules and biologically active substances, in particular nucleic acids from biological and biochemical sample material; chromatography columns for laboratory use; sample preparation instruments for isolation of nucleic acid or proteins and spare parts and add-ons, namely, laboratory pipettes, laboratory pipette tips, laboratory pipette tip holders; laboratory equipment, namely, magnetic particles, thermocyclers for the purpose of performing polymerase chain reactions, homogenizers to homogenize samples for subsequent isolation of nucleic acids or proteins, vacuum valves for the purpose of permitting the operation of laboratory processes under subatmospheric pressureACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 21, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Nov 30, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Nov 30, 2022FIMPFINAL DISPOSITION PROCESSED
Nov 23, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 23, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 23, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 7, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 18, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 9, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 29, 2022FIXDELECTRONIC RECORD REVIEW COMPLETE
Apr 20, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 20, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 1, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Mar 27, 2022ALIEASSIGNED TO LIE
Mar 25, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 28, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2021RFNTREFUSAL PROCESSED BY IB
Feb 4, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 4, 2021RFRRREFUSAL PROCESSED BY MPU
Jan 22, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 21, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2020DOCKASSIGNED TO EXAMINER
Nov 24, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Nov 20, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 19, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance